Hims & Hers Health, Inc.
HIMSNew York Stock ExchangeFull coverage
Price
Loading your watchlists
Balance sheet
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||
| Short-term investments | ||||||||
| Available-for-sale debt securities, current | ||||||||
| Receivables, total | ||||||||
| Accounts receivable | ||||||||
| Inventories | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Prepaid expenses | ||||||||
| Other current assets | ||||||||
| Total current assets | ||||||||
| Property, plant and equipment, including finance lease assets | ||||||||
| Property, plant and equipment | ||||||||
| Accumulated depreciation | ||||||||
| Operating lease right-of-use assets | ||||||||
| Long-term investments | ||||||||
| Available-for-sale debt securities, non-current | ||||||||
| Goodwill | ||||||||
| Intangible assets | ||||||||
| Finite-lived intangible assets | ||||||||
| Deferred tax assets | ||||||||
| Restricted cash, non-current | ||||||||
| Other non-current assets | ||||||||
| Total non-current assets | ||||||||
| Total assets | ||||||||
| Available-for-sale debt securities | ||||||||
| Accounts payable and accrued liabilities | ||||||||
| Accounts payable | ||||||||
| Accrued liabilities | ||||||||
| Accrued compensation | ||||||||
| Operating lease liabilities, current | ||||||||
| Deferred revenue | ||||||||
| Taxes payable | ||||||||
| Total current liabilities | ||||||||
| Long-term debt and finance lease liabilities | ||||||||
| Long-term debt | ||||||||
| Operating lease liabilities | ||||||||
| Deferred tax liabilities | ||||||||
| Other non-current liabilities | ||||||||
| Total non-current liabilities | ||||||||
| Total liabilities | ||||||||
| Operating lease liabilities, total | ||||||||
| Redeemable (temporary) equity | ||||||||
| Temporary equity attributable to the company | ||||||||
| Common stock and paid-in capital | ||||||||
| Common stock | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Accumulated other comprehensive income | ||||||||
| Shareholders' equity | ||||||||
| Total equity | ||||||||
| Total liabilities and equity | ||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Diluted share count |
Margins
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin |